Xeris Biopharma Holdings, Inc. (XERS) Hit a 52 Week High, Can the Run Continue?

Shares of Xeris Biopharma (XERS) have been strong performers lately, with the stock up 19.7% over the past month. The stock hit a new 52-week high of $9.41 in the previous session. Xeris Biopharma has gained 172.6% since the start of the year compared to the 0.7% gain for the Zacks Medical sector and the 8.1% return for the Zacks Medical - Drugs industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, having beaten the Zacks Consensus Estimate in each of ...